The Biden Admin. chose 10 expensive prescription drugs for price negotiations with pharmaceutical manufacturers.

More than half the drugs selected for an initial round of price negotiations are medications to prevent blood clots and treat diabetes, and were taken by millions of people on Medicare in the past year.